The Equity in Newborn Drug Screening (ENDS) Study: How Family Medicine Teams Can Mobilize for Change with Antiracist Methods and Practices
P. Paul Chandanabhumma, Lauren Oshman and Justine Wu
Abstract
Speakers
🪄 Outline
Discussion
Article of record
The Equity in Newborn Drug Screening (ENDS) Study: How Family Medicine Teams Can Mobilize for Change with Antiracist Methods and Practices
P. Paul Chandanabhumma
University of Michigan–Ann Arbor and Michigan Medicine
Lauren Oshman
University of Michigan–Ann Arbor
Justine Wu
University of Michigan–Ann Arbor
Learning Objectives:
- Describe at least two social justice frameworks, including community engagement and antiracism, that can be applied in healthcare research and clinical care to address real-world problems and promote health equity.
- Identify at least three ways in which family physicians and learners can meaningfully contribute to antiracist efforts to improve research, education, and clinical care.
- Describe the potential harms that may result from newborn drug screening on families and ways to mitigate this harm through clinical practice and healthcare policy.
References
Grants
- University of MichiganOVPR Antiracism Grant
Brown Family Medicine Primary Care Innovation Series
Family Medicine (Brown University)Cite as
P. Paul Chandanabhumma et al. (2024, May 30), The Equity in Newborn Drug Screening (ENDS) Study: How Family Medicine Teams Can Mobilize for Change with Antiracist Methods and Practices
Share
Details
Listed seminar This seminar is open to all
Recorded Available to all
Video length 1:08:27
Q&A Now closed